These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 22525741
1. Characterization of urinary bile acids in a pediatric BRIC-1 patient: effect of rifampicin treatment. Mizuochi T, Kimura A, Tanaka A, Muto A, Nittono H, Seki Y, Takahashi T, Kurosawa T, Kage M, Takikawa H, Matsuishi T. Clin Chim Acta; 2012 Aug 16; 413(15-16):1301-4. PubMed ID: 22525741 [Abstract] [Full Text] [Related]
2. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Klomp LW, Vargas JC, van Mil SW, Pawlikowska L, Strautnieks SS, van Eijk MJ, Juijn JA, Pabón-Peña C, Smith LB, DeYoung JA, Byrne JA, Gombert J, van der Brugge G, Berger R, Jankowska I, Pawlowska J, Villa E, Knisely AS, Thompson RJ, Freimer NB, Houwen RH, Bull LN. Hepatology; 2004 Jul 16; 40(1):27-38. PubMed ID: 15239083 [Abstract] [Full Text] [Related]
3. Successful treatment with colestimide for a bout of cholestasis in a Japanese patient with benign recurrent intrahepatic cholestasis caused by ATP8B1 mutation. Uegaki S, Tanaka A, Mori Y, Kodama H, Fukusato T, Takikawa H. Intern Med; 2008 Jul 16; 47(7):599-602. PubMed ID: 18379143 [Abstract] [Full Text] [Related]
4. Benign recurrent intrahepatic cholestasis: altered bile acid metabolism. Bijleveld CM, Vonk RJ, Kuipers F, Havinga R, Boverhof R, Koopman BJ, Wolthers BG, Fernandes J. Gastroenterology; 1989 Aug 16; 97(2):427-32. PubMed ID: 2744357 [Abstract] [Full Text] [Related]
5. Benign recurrent intrahepatic cholestasis: review and long-term follow-up of five cases. Folvik G, Hilde O, Helge GO. Scand J Gastroenterol; 2012 Apr 16; 47(4):482-8. PubMed ID: 22229830 [Abstract] [Full Text] [Related]
6. A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Pawlikowska L, Groen A, Eppens EF, Kunne C, Ottenhoff R, Looije N, Knisely AS, Killeen NP, Bull LN, Elferink RP, Freimer NB. Hum Mol Genet; 2004 Apr 15; 13(8):881-92. PubMed ID: 14976163 [Abstract] [Full Text] [Related]
7. [Abnormal bile acids in benign recurrent intrahepatic cholestasis]. Endo T. Nihon Rinsho; 1984 Jul 15; 42(7):1618-24. PubMed ID: 6492403 [No Abstract] [Full Text] [Related]
8. ATP8B1 and ATP11C: Two Lipid Flippases Important for Hepatocyte Function. Naik J, de Waart DR, Utsunomiya K, Duijst S, Mok KH, Oude Elferink RP, Bosma PJ, Paulusma CC. Dig Dis; 2015 Jul 15; 33(3):314-8. PubMed ID: 26045263 [Abstract] [Full Text] [Related]
9. Hydroxylation of cholic, chenodeoxycholic, and deoxycholic acids in patients with intrahepatic cholestasis. Bremmelgaard A, Sjövall J. J Lipid Res; 1980 Nov 15; 21(8):1072-81. PubMed ID: 7462803 [Abstract] [Full Text] [Related]
10. Serum bile acid concentrations in the course of benign recurrent intrahepatic cholestasis. Finni K, Similä S, Heikura S, Jänne O, Mäentausta O. Ann Clin Res; 1980 Aug 15; 12(4):168-71. PubMed ID: 7259083 [Abstract] [Full Text] [Related]
11. Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids. González R, Cruz A, Ferrín G, López-Cillero P, Briceño J, Gómez MA, Rufián S, Padillo J, De la Mata M, Marin JJ, Muntané J. J Hepatobiliary Pancreat Sci; 2011 Sep 15; 18(5):740-50. PubMed ID: 21526375 [Abstract] [Full Text] [Related]
12. FIC1 disease: a spectrum of intrahepatic cholestatic disorders. van Mil SW, Klomp LW, Bull LN, Houwen RH. Semin Liver Dis; 2001 Nov 15; 21(4):535-44. PubMed ID: 11745041 [Abstract] [Full Text] [Related]
13. Profile of urinary bile acids in familial intrahepatic cholestasis with Coombs' negative haemolytic anaemia. Kimura A, Ushijima K, Suzuki M, Tohma M, Inokuchi T, Kato H. Acta Paediatr; 1995 Oct 15; 84(10):1119-24. PubMed ID: 8563222 [Abstract] [Full Text] [Related]
14. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy. Geenes V, Chambers J, Khurana R, Shemer EW, Sia W, Mandair D, Elias E, Marschall HU, Hague W, Williamson C. Eur J Obstet Gynecol Reprod Biol; 2015 Jun 15; 189():59-63. PubMed ID: 25864112 [Abstract] [Full Text] [Related]
15. Benign recurrent intrahepatic cholestasis: a long-term follow-up. Nakamuta M, Sakamoto S, Miyata Y, Sato M, Nawata H. Hepatogastroenterology; 1994 Jun 15; 41(3):287-9. PubMed ID: 7959556 [Abstract] [Full Text] [Related]
16. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism. Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD. Hepatology; 1991 Jun 15; 13(6):1076-83. PubMed ID: 2050325 [Abstract] [Full Text] [Related]
17. Progressive familial intrahepatic cholestasis. Cavestro GM, Frulloni L, Cerati E, Ribeiro LA, Corrente V, Sianesi M, Franzè A, Di Mario F. Acta Biomed; 2002 Jun 15; 73(3-4):53-6. PubMed ID: 12596388 [Abstract] [Full Text] [Related]
18. Benign recurrent intrahepatic cholestasis: late initial diagnosis in adulthood. Ermis F, Oncu K, Ozel M, Yazgan Y, Gurbuz AK, Demirturk L, Demirci H, Akyol T, Hahoglu A. Ann Hepatol; 2010 Jun 15; 9(2):207-10. PubMed ID: 20526019 [Abstract] [Full Text] [Related]
19. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Bull LN, van Eijk MJ, Pawlikowska L, DeYoung JA, Juijn JA, Liao M, Klomp LW, Lomri N, Berger R, Scharschmidt BF, Knisely AS, Houwen RH, Freimer NB. Nat Genet; 1998 Mar 15; 18(3):219-24. PubMed ID: 9500542 [Abstract] [Full Text] [Related]
20. Bile acid metabolism in benign recurrent intrahepatic cholestasis. Comparative studies on the icteric and anicteric phases of a single case. Endo T, Uchida K, Amuro Y, Higashino K, Yamamura Y. Gastroenterology; 1979 May 15; 76(5 Pt 1):1002-6. PubMed ID: 437403 [Abstract] [Full Text] [Related] Page: [Next] [New Search]